Literature DB >> 17571235

Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics?

Silvie Lacigová1, Petr Safránek, Daniela Cechurová, Michal Krcma, Jakub Vísek, Zdenek Jankovec, Michal Zourek, Iva Haladová, Zdenek Rusavý.   

Abstract

BACKGROUND AND AIMS: Diabetic cardiovascular autonomic neuropathy (CAN) is associated with increased morbidity and mortality. This complication may be asymptomatic for a long time. The aim of this study was to assess the prevalence, severity and predictors of asymptomatic CAN in patients with type 1 diabetes mellitus (DM1). PATIENTS AND METHODS: 107 patients with DM1 were enrolled: 52 men and 55 women aged 39.8 +/- 12.4 years (18-72), duration of DM 16.6 +/- 9.5 years (0.5-43), age at DM manifestation 23.5 +/- 12.8 years (1-54) and BMI 25.1 +/- 3.2 (18.9-33.91). CAN was assessed using standard cardiovascular reflex tests (Ewing battery) and the patients were divided into three groups according to the results: Group 0, without CAN; Group I, 1(st) degree CAN; Group II, 2(nd) degree CAN. We assessed the most frequent relationships between CAN and chronic complications, episodes of severe hypoglycemia, time-related parameters (age of patients, duration of diabetes, age at manifestation), glycosylated hemoglobin (HbA(1)c), BMI, cardiovascular diseases and blood pressure, and determined the predictability of CAN on the basis of these relationships.
RESULTS: Only 50 of the 107 patients (46%) showed no CAN. We found 1(st) degree CAN in 38 patients (36%) and 2(nd) degree CAN in 19 (18%). CAN correlated more significantly with the duration of diabetes (p < 0.001) than with age (p < 0.05). The relationship between CAN and HbA(1)c was on the borderline of statistical significance (p = 0.053). We found a positive correlation between CAN and the presence of chronic complications [peripheral neuropathy (p < 0.001), retinopathy (p < 0.001), and some markers of nephropathy: creatinine (p < 0.03), albuminuria (p < 0.01)]. Although blood pressure was within the physiological range (124.2/74.5 +/- 11.5/7.8 mmHg) in all patients, a positive correlation with CAN was confirmed (p < 0.05). No relationship with occurrence of severe hypoglycemia was found.
CONCLUSIONS: According to our results, asymptomatic CAN is very frequent in patients with DM1. By using multifactorial logistic regression (step-wise) analysis we demonstrated that if albuminuria, peripheral neuropathy and elevated systolic BP are present simultaneously, there is a high probability that the patient also has CAN (84.9% of initial group correctly predicted, p < 0.001).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571235     DOI: 10.1007/s00508-007-0789-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  33 in total

1.  Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy.

Authors:  A J Burger; L A Weinrauch; J A D'Elia; D Aronson
Journal:  Am J Cardiol       Date:  1999-09-15       Impact factor: 2.778

2.  Risk factors of autonomic and sensory nerve dysfunction in patients with newly diagnosed type 1 diabetes.

Authors:  Katalin Keresztes; Ildiko Istenes; Zsolt Hermanyi; Peter Vargha; Istvan Barna; Peter Kempler
Journal:  Diabetes Care       Date:  2003-07       Impact factor: 19.112

3.  Factors involved in cardiac autonomic neuropathy in diabetic patients.

Authors:  P Valensi; J P Huard; C Giroux; J R Attali
Journal:  J Diabetes Complications       Date:  1997 May-Jun       Impact factor: 2.852

Review 4.  Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment.

Authors:  Raelene E Maser; M James Lenhard
Journal:  J Clin Endocrinol Metab       Date:  2005-07-12       Impact factor: 5.958

5.  Impact of body mass on autonomic function in persons with type 2 diabetes.

Authors:  N Tentolouris; E Grapsas; E Stambulis; K Papageorgiou; N Katsilambros
Journal:  Diabetes Res Clin Pract       Date:  1999-10       Impact factor: 5.602

6.  Relationship between nephropathy, retinopathy, and autonomic neuropathy in patients with type I diabetes.

Authors:  P Pontuch; J Vozár; M Potocký; B Krahulec
Journal:  J Diabet Complications       Date:  1990 Oct-Dec

7.  Association of increased plantar pressures with peripheral sensorimotor and peripheral autonomic neuropathy in Type 2 diabetic patients.

Authors:  R Lobmann; G Kasten; U Kasten; H Lehnert
Journal:  Diabetes Nutr Metab       Date:  2002-06

8.  Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity.

Authors:  B Bergström; B Lilja; S Osterlin; G Sundkvist
Journal:  J Intern Med       Date:  1990-01       Impact factor: 8.989

9.  Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients.

Authors:  V Spallone; S Gambardella; M R Maiello; A Barini; S Frontoni; G Menzinger
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

10.  [Prevalence of cardiac autonomic neuropathies in uremia and diabetes mellitus].

Authors:  T Kästenbauer; M Auinger; K Irsigler
Journal:  Wien Klin Wochenschr       Date:  1994       Impact factor: 1.704

View more
  1 in total

1.  Screening for diabetic cardiac autonomic neuropathy using a new handheld device.

Authors:  Elisabeth Gulichsen; Jesper Fleischer; Niels Ejskjaer; Ebbe Eldrup; Lise Tarnow
Journal:  J Diabetes Sci Technol       Date:  2012-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.